ADT1360-Ligelizumab Biosimilar-Anti-IgE mAb-Research Grade
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1360 |
Product Name |
ADT1360-Ligelizumab Biosimilar-Anti-IgE mAb-Research Grade |
Alternate Names |
anti human ige, anti human ige antibody, anti ige antibodies, anti ige antibody, anti-human ige antibody, anti-mouse ige antibody, ige antibodies, ige antibody |
Alias |
CL-2C |
Clonity |
Monoclonal |
Host |
CHO Cells |
Species |
Human |
Target |
IgE |
Gene ID |
3497 |
Isotype |
IgG1 Kappa |
Size |
100ug, 1mg, 5mg |
Research Area |
Immunology |
CAS Number |
1322627-61-1 |
Product Description |
Ligelizumab is a humanized IgG1 monoclonal antibody designed for the treatment of severe asthma and chronic spontaneous urticaria. It is an anti-IgE that binds to IGHE an acts as an immunomodulator. |
Mechanism of Action |
Immunoglobulin E (IgE) is a key driver of hypersensitivity reactions, and has thus become an attractive target in the treatment of immune-mediated hypersensitivity disorders. Immediate hypersensitivity reactions are due to IgE binding with FcεRI, which activates allergic effector cells that undergo degranulation to release vasoactive and pro-inflammatory mediators. IgE also binds to CD23/FcεRII, which appears responsible for antigen presentation, antigen transport across airway/epithelial barriers, and the regulation of IgE synthesis. |
Application |
WB, IF, IP, Neut, Functional assay, ELISA, FC |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
|
Reference 1. Lee JH, et al. Sci Rep, 2023 Apr 19. PMID 37076662
2. Patel NH, et al. Indian J Dermatol Venereol Leprol, 2021 Mar-Apr. PMID 33769756
3. Li J, et al. Mol Med Rep, 2020 Jul. PMID 32319635
|





